Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9935)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2016 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Motamed N, Sohrabi M, Ajdarkosh H, Hemmasi G, Maadi M, Sayeedian FS, Pirzad R, Abedi K, Aghapour S, Fallahnezhad M, Zamani F. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(10): 3023-3030 [PMID: 26973398 DOI: 10.3748/wjg.v22.i10.3023] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i10/3023.htm |
| Number | Citing Articles |
| 1 |
Wenhuan Feng, Caixia Gao, Yan Bi, Min Wu, Ping Li, Shanmei Shen, Wei Chen, Tingting Yin, Dalong Zhu. Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non‐alcoholic fatty liver disease. Journal of Diabetes 2017; 9(8): 800 doi: 10.1111/1753-0407.12555
|
| 2 |
Pegah Golabi, James M. Paik, Tamoore Arshad, Youssef Younossi, Alita Mishra, Zobair M. Younossi. Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities. Hepatology Communications 2020; 4(8): 1136 doi: 10.1002/hep4.1534
|
| 3 |
Maryam Chegeni, Sairan Nili, Mehdi Darabi, Elham Gheysvandi, Razieh Zahedi, Elham Sharifian, HamidReza Shoraka, Mohammad Rostamkhani, LeiliAbedi Gheshlaghi. Prevalence of non-alcoholic fatty liver and its related factors in Iran: Systematic review and meta-analysis. Journal of Education and Health Promotion 2023; 12(1): 356 doi: 10.4103/jehp.jehp_1056_22
|
| 4 |
Zahra Dehnavi, Farkhonde Razmpour, Mahmoud Belghaisi Naseri, Mohsen Nematy, Seyed Ali Alamdaran, Hassan Ali Vatanparast, Mohsen Azimi Nezhad, Bita Abbasi, Azita Ganji. Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD). Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.63227
|
| 5 |
Elif Ozsu, Bahadır Yazıcıoğlu. Obese boys with low concentrations of high-density lipoprotein cholesterol are at greater risk of hepatosteatosis. Hormones 2019; 18(4): 477 doi: 10.1007/s42000-019-00152-2
|
| 6 |
Marcin Kosmalski, Rafał Frankowski, Monika Różycka-Kosmalska, Kasper Sipowicz, Tadeusz Pietras, Łukasz Mokros. The Association between Personality Factors and Metabolic Parameters among Patients with Non-Alcoholic-Fatty Liver Disease and Type 2 Diabetes Mellitus—A Cross-Sectional Study. Journal of Clinical Medicine 2023; 12(13): 4468 doi: 10.3390/jcm12134468
|
| 7 |
Daniele Pastori, Angela Sciacqua, Rossella Marcucci, Alessio Farcomeni, Francesco Perticone, Maria Del Ben, Francesco Angelico, Francesco Baratta, Pasquale Pignatelli, Francesco Violi, Mirella Saliola, Maria Santulli, Fortunata Vasaturo, Marco Antonio Casciaro, Vittoria Cammisotto, Cristina Nocella, Simona Bartimoccia, Roberto Carnevale, Claudia Iannilli, Tiziana Di Stefano, Patrizia Iannucci, Elio Sabbatini. Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation. Mayo Clinic Proceedings 2020; 95(3): 513 doi: 10.1016/j.mayocp.2019.08.027
|
| 8 |
Ahmed M. F. Mansour, Essam M. Bayoumy, Ahmed M. ElGhandour, Mohamed Darwish El-Talkawy, Sameh M. Badr, Ahmed El-Metwally Ahmed. Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00044-w
|
| 9 |
Yan Xue, Jiahui Xu, Man Li, Yueqiu Gao. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: Triglyceride glucose index–related parameters. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.951689
|
| 10 |
Yu Kong, Zhongcai Yao, Lingli Ren, Liqin Zhou, Jinkai Zhao, Yuanyuan Qian, Dayong Lou. Depression and hepatobiliary diseases: a bidirectional Mendelian randomization study. Frontiers in Psychiatry 2024; 15 doi: 10.3389/fpsyt.2024.1366509
|
| 11 |
Jong Wook Choi, Il Hwan Oh, Chang Hwa Lee, Joon-Sung Park. Is there a J-shaped relationship between the fatty liver index and risk of microalbuminuria in the general population?. Clinica Chimica Acta 2018; 481: 231 doi: 10.1016/j.cca.2017.08.015
|
| 12 |
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. La utilidad clínica de la elastografía transitoria como una herramienta de imagenología para evaluar el impacto a corto plazo de la gastrectomía laparoscópica en manga, en conjunto con parámetros clínicos y bioquímicos e índices clínico-bioquímicos en pacientes con enfermedad de hígado graso no alcohólico: un estudio piloto egipcio. Revista de Gastroenterología de México 2021; 86(2): 125 doi: 10.1016/j.rgmx.2020.04.007
|
| 13 |
Hsun-Chin Chao, Hsin-Yeh Lin. Comparison of Body Mass Index and Fat Indices in Predicting the Severity of Nonalcoholic Fatty Liver Disease Among Children Who Are Overweight and Obese. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.724426
|
| 14 |
Antonio J. Amor, Montserrat Cofán, Rocío Mateo-Gallego, Ana Cenarro, Fernando Civeira, Emilio Ortega, Emilio Ros, Aleix Sala-Vila. Dietary polyunsaturated fatty acids mediate the inverse association of stearoyl-CoA desaturase activity with the risk of fatty liver in dyslipidaemic individuals. European Journal of Nutrition 2019; 58(4): 1561 doi: 10.1007/s00394-018-1691-4
|
| 15 |
Stefan Kabisch, Mariya Markova, Silke Hornemann, Stephanie Sucher, Olga Pivovarova-Ramich, Jürgen Machann, Johannes Hierholzer, Sascha Rohn, Andreas F. H. Pfeiffer. Liver fat scores do not reflect interventional changes in liver fat content induced by high-protein diets. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87360-2
|
| 16 |
Lin Ning, Jianguang Sun. Associations between body circumference and testosterone levels and risk of metabolic dysfunction-associated fatty liver disease: a mendelian randomization study. BMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-15467-4
|
| 17 |
Ladislav Turecký, Viera Kupčová, Monika Ďurfinová, Marcel Repiský, Eva Uhlíková. Serum butyrylcholinesterase/HDL-cholesterol ratio and atherogenic index of plasma in patients with fatty liver disease. Vnitřní lékařství 2021; 67(2): e04 doi: 10.36290/vnl.2021.027
|
| 18 |
Shubham Kumari, Xuena Wang, Yunyun Liu, Yeqing Gu, Yuhan Huang, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Guolin Wang, Kun Song, Kaijun Niu. Height predict incident non-alcoholic fatty liver disease among general adult population in Tianjin, China, independent of body mass index, waist circumference, waist-to-height ratio, and metabolic syndrome. BMC Public Health 2020; 20(1) doi: 10.1186/s12889-020-08475-1
|
| 19 |
Robert Ross, Simrat Soni, Sarah Houle. Negative Energy Balance Induced by Exercise or Diet: Effects on Visceral Adipose Tissue and Liver Fat. Nutrients 2020; 12(4): 891 doi: 10.3390/nu12040891
|
| 20 |
Yang Xia, Limin Cao, Yashu Liu, Xuena Wang, Shunming Zhang, Ge Meng, Qing Zhang, Li Liu, Hongmei Wu, Yeqing Gu, Yawen Wang, Tingjing Zhang, Xing Wang, Shaomei Sun, Ming Zhou, Qiyu Jia, Kun Song, Kaijun Niu, Yuhong Zhao. Longitudinal Associations Between Hand Grip Strength and Non-Alcoholic Fatty Liver Disease in Adults: A Prospective Cohort Study. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.752999
|
| 21 |
Paula Iruzubieta, Marta González, Joaquín Cabezas, María Teresa Arias-Loste, Javier Crespo. Liver Research and Clinical Management. 2018; doi: 10.5772/intechopen.72668
|
| 22 |
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca. The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Diagnostics 2023; 13(21): 3316 doi: 10.3390/diagnostics13213316
|
| 23 |
Behnam Rabiee, Farzin Roozafzai, Gholam Reza Hemasi, Hossein Poustchi, Hossein Keyvani, Mahmood Reza Khonsari, Hossein Ajdarkosh, Mansooreh Maadi, Fatemeh Sima Saeedian, Farhad Zamani. The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population. Middle East Journal of Digestive Diseases 2017; 9(2): 86 doi: 10.15171/mejdd.2017.56
|
| 24 |
Marija Mitrović, Vojko Mišević, Ljiljana Popović. Correlation of FLI fatty liver index with insulin resistance indices in patients with metabolic syndrome. Medicinski podmladak 2023; 74(3): 58 doi: 10.5937/mp74-40416
|
| 25 |
Nima Motamed, Behnam Rabiee, Gholam Reza Hemasi, Hossein Ajdarkosh, Mahmood Reza Khonsari, Mansooreh Maadi, Hossein Keyvani, Farhad Zamani. Body Roundness Index and Waist-to-Height Ratio are Strongly Associated With Non-Alcoholic Fatty Liver Disease: A Population-Based Study. Hepatitis Monthly 2016; 16(9) doi: 10.5812/hepatmon.39575
|
| 26 |
M.ª Teófila Vicente-Herrero, M.ª Victoria Ramírez-Iñiguez de la Torre, Ángel Arturo López González. Obesidad, hábitos de vida y valoración FLI en la población laboral española durante la pandemia. Revista Clínica de Medicina de Familia 2022; : 93 doi: 10.55783/rcmf.150205
|
| 27 |
Pernille H. Hellmann, Jonatan I. Bagger, Katrine R. Carlander, Julie Forman, Elizaveta Chabanova, Jens S. Svenningsen, Jens J. Holst, Matthew P. Gillum, Tina Vilsbøll, Filip K. Knop. The effect of curcumin on hepatic fat content in individuals with obesity. Diabetes, Obesity and Metabolism 2022; 24(11): 2192 doi: 10.1111/dom.14804
|
| 28 |
Stefan Kabisch, Sabrina Bäther, Ulrike Dambeck, Margrit Kemper, Christiana Gerbracht, Caroline Honsek, Anna Sachno, Andreas Pfeiffer. Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet. Nutrients 2018; 10(2): 157 doi: 10.3390/nu10020157
|
| 29 |
Maria Perticone, Antonio Cimellaro, Raffaele Maio, Benedetto Caroleo, Angela Sciacqua, Giorgio Sesti, Francesco Perticone. Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients. International Journal of Molecular Sciences 2016; 17(4): 456 doi: 10.3390/ijms17040456
|
| 30 |
Shelley E. Keating, Helen M. Parker, Ingrid J. Hickman, Sjaan R. Gomersall, Matthew P. Wallen, Jeff S. Coombes, Graeme A. Macdonald, Jacob George, Nathan A. Johnson. NAFLD in clinical practice: Can simple blood and anthropometric markers be used to detect change in liver fat measured by 1H‐MRS?. Liver International 2017; 37(12): 1907 doi: 10.1111/liv.13488
|
| 31 |
Naeimeh Atabaki-Pasdar, Mattias Ohlsson, Ana Viñuela, Francesca Frau, Hugo Pomares-Millan, Mark Haid, Angus G. Jones, E. Louise Thomas, Robert W. Koivula, Azra Kurbasic, Pascal M. Mutie, Hugo Fitipaldi, Juan Fernandez, Adem Y. Dawed, Giuseppe N. Giordano, Ian M. Forgie, Timothy J. McDonald, Femke Rutters, Henna Cederberg, Elizaveta Chabanova, Matilda Dale, Federico De Masi, Cecilia Engel Thomas, Kristine H. Allin, Tue H. Hansen, Alison Heggie, Mun-Gwan Hong, Petra J. M. Elders, Gwen Kennedy, Tarja Kokkola, Helle Krogh Pedersen, Anubha Mahajan, Donna McEvoy, Francois Pattou, Violeta Raverdy, Ragna S. Häussler, Sapna Sharma, Henrik S. Thomsen, Jagadish Vangipurapu, Henrik Vestergaard, Leen M. ‘t Hart, Jerzy Adamski, Petra B. Musholt, Soren Brage, Søren Brunak, Emmanouil Dermitzakis, Gary Frost, Torben Hansen, Markku Laakso, Oluf Pedersen, Martin Ridderstråle, Hartmut Ruetten, Andrew T. Hattersley, Mark Walker, Joline W. J. Beulens, Andrea Mari, Jochen M. Schwenk, Ramneek Gupta, Mark I. McCarthy, Ewan R. Pearson, Jimmy D. Bell, Imre Pavo, Paul W. Franks, Dominik Heider. Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts. PLOS Medicine 2020; 17(6): e1003149 doi: 10.1371/journal.pmed.1003149
|
| 32 |
Maurizio Parola, Pietro Vajro. Nocturnal hypoxia in obese-related obstructive sleep apnea as a putative trigger of oxidative stress in pediatric NAFLD progression. Journal of Hepatology 2016; 65(3): 470 doi: 10.1016/j.jhep.2016.05.042
|
| 33 |
Jing Qiu, Zhiwei Zhou, Jie Wang, Yiying Wang, Chunxing Liu, Xingxiang Liu, Yunfang Xu, Lugang Yu, Hui Zhou, Jie Lin, Zhirong Guo, Chen Dong, Pavel Strnad. Associations between fatty liver index and asymptomatic intracranial vertebrobasilar stenosis in Chinese population. PLOS ONE 2017; 12(11): e0187502 doi: 10.1371/journal.pone.0187502
|
| 34 |
Prashant Bafna, Rasmi Ranjan Sahoo, Kasturi Hazarika, Manesh Manoj, Sumit Rungta, Anupam Wakhlu. Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis. Clinical Rheumatology 2021; 40(9): 3605 doi: 10.1007/s10067-021-05678-8
|
| 35 |
Xian-Pei Xiao, Yong-Jun Dai, Yu Zhang, Meng Yang, Jian Xie, Guo Chen, Zheng-Jun Yang. Investigating the causal associations between five anthropometric indicators and nonalcoholic fatty liver disease: Mendelian randomization study. World Journal of Clinical Cases 2024; 12(7): 1215-1226 doi: 10.12998/wjcc.v12.i7.1215
Abstract(92) |
Core Tip(75) |
Full Article(HTML)(599)
|
Full Article with Cover (PDF)-2280K(48)
|
Audio-1825K(1)
|
Peer-Review Report-192K(8)
|
Answering Reviewers-176K(7)
|
Supplementary Material-6950K(15)
|
Full Article (PDF)-2043K(38)
|
Full Article (XML)-153K(13)
|
Times Cited (0)
|
Total Visits (1241)
|
Open
|
| 36 |
Tanya Mohammadi, Babak Mohammadi. Screening the General Population for Non-Alcoholic Fatty Liver Disease: Model Development and Validation. Archives of Medical Research 2024; 55(3): 102987 doi: 10.1016/j.arcmed.2024.102987
|
| 37 |
Orit Goldman, Ofir Ben-Assuli, Ori Rogowski, David Zeltser, Itzhak Shapira, Shlomo Berliner, Shira Zelber-Sagi, Shani Shenhar-Tsarfaty. Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine. Journal of Medical Systems 2021; 45(2) doi: 10.1007/s10916-020-01693-5
|
| 38 |
Hongye Peng, Liang Pan, Simiao Ran, Miyuan Wang, Shuxia Huang, Mo Zhao, Zhengmin Cao, Ziang Yao, Lei Xu, Qing Yang, Wenliang Lv. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1083032
|
| 39 |
Richard Buendia, Monica Zambrano, Andres Ricardo Buendia Jaime, Raquel Ramirez, Alfonso Kerguelen. Nutrition in the Prevention and Treatment of Abdominal Obesity. 2019; : 73 doi: 10.1016/B978-0-12-816093-0.00007-0
|
| 40 |
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus 2021; doi: 10.7759/cureus.20776
|
| 41 |
Marcin Kosmalski, Izabela Szymczak-Pajor, Józef Drzewoski, Agnieszka Śliwińska. Non-Alcoholic Fatty Liver Disease Is Associated with a Decreased Catalase (CAT) Level, CT Genotypes and the T Allele of the -262 C/T CAT Polymorphism. Cells 2023; 12(18): 2228 doi: 10.3390/cells12182228
|
| 42 |
Paul Cordero, Jiawei Li, Jude A. Oben. Obesity. Endocrinology 2019; : 179 doi: 10.1007/978-3-319-46933-1_20
|
| 43 |
Paul Cordero, Jiawei Li, Jude A. Oben. Thyroid Diseases. Endocrinology 2018; : 1 doi: 10.1007/978-3-319-47685-8_20-1
|
| 44 |
Juan Wu, Shen Tian, Hao Li, Zhou Xu, Shu Li, Yu-ling Chen, Xin-yu Liang, Jun Xiao, Jing-yu Song, Rui-ling She, Chen-yu Ma, Jun-han Feng, Zhao-xing Li, Zhi-yu Jiang, Zi-wei Zhang, Kai-nan Wu, Ling-quan Kong. Population-specific cut-off points of fatty liver index: a study based on the National Health and Nutrition Examination Survey data. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02303-z
|
| 45 |
Milena Peličić, Milica Petrović, Ljiljana Popović. Fatty liver indices in obese and non-obese patients with dyslipidemia. Medicinski podmladak 2023; 74(6): 61 doi: 10.5937/mp74-39378
|
| 46 |
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot study. Revista de Gastroenterología de México (English Edition) 2021; 86(2): 125 doi: 10.1016/j.rgmxen.2020.04.008
|
| 47 |
Bahareh Amirkalali, Masoud Reza Sohrabi, Ali Gholami, Payam Hosseinzadeh, Farzad Shidfar, Farhad Zamani. Interpretation of Serum Visfatin Level in Relation to Hepatic Injury is Probably Gender Dependent in Nonalcoholic Fatty Liver Disease. Hepatitis Monthly 2017; 17(7) doi: 10.5812/hepatmon.13242
|
| 48 |
Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(31): 7006-7016 doi: 10.3748/wjg.v22.i31.7006
|
| 49 |
Emilio Molina-Molina, Harshitha Shanmugam, Agostino Di Ciaula, Ignazio Grattagliano, Domenica Maria Di Palo, Vincenzo O. Palmieri, Piero Portincasa. (13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle. JHEP Reports 2021; 3(1): 100203 doi: 10.1016/j.jhepr.2020.100203
|
| 50 |
Marium Ahmed, Rabeeya Saeed, Lubna Kamani, Noureen Durrani, Faraz Ahmed. Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease. Journal of Family Medicine and Primary Care 2024; 13(4): 1488 doi: 10.4103/jfmpc.jfmpc_1789_23
|
| 51 |
Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Alessandra Marrazzo, Dante Romagnoli, Amedeo Lonardo. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. Advances in Therapy 2017; 34(6): 1291 doi: 10.1007/s12325-017-0556-1
|
| 52 |
Nima Motamed, Farhad Zamani, Mansooreh Maadi, Hossein Ajdarkosh, Farzin Roozafzai, Hossein Keyvani, Hossein Poustchi, Ramin Shakeri, G. Hossein Ashrafi, Dhayaneethie Perumal, Behnam Rabiee, Maziar Moradi-Lakeh, Mahmoodreza Khoonsari, Zahedin Kheyri, Masoud Reza Sohrabi, Azam Doustmohammadian, Bahareh Amirkalali, Fahimeh Safarnezhad Tameshkel, Esmaeel Gholizadeh, Seyed Hamzeh Hosseini, Mohammad Hadi Karbalaie Niya. A population-based prospective study on obesity-related non-communicable diseases in northern Iran: rationale, study design, and baseline analysis. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1329380
|
| 53 |
Michael H. Le, Yee Hui Yeo, Xiaohe Li, Jie Li, Biyao Zou, Yuankai Wu, Qing Ye, Daniel Q. Huang, Changqing Zhao, Jie Zhang, Chenxi Liu, Na Chang, Feng Xing, Shiping Yan, Zi Hui Wan, Natasha Sook Yee Tang, Maeda Mayumi, Xinting Liu, Chuanli Liu, Fajuan Rui, Hongli Yang, Yao Yang, Ruichun Jin, Richard H.X. Le, Yayun Xu, David M. Le, Scott Barnett, Christopher Donald Stave, Ramsey Cheung, Qiang Zhu, Mindie H. Nguyen. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2022; 20(12): 2809 doi: 10.1016/j.cgh.2021.12.002
|
| 54 |
Marcin Kosmalski, Józef Drzewoski, Izabela Szymczak-Pajor, Andrzej Zieleniak, Melania Mikołajczyk-Solińska, Jacek Kasznicki, Agnieszka Śliwińska. Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD). Biomedicines 2022; 10(9): 2253 doi: 10.3390/biomedicines10092253
|
| 55 |
Raquel Cano, José Pérez, Lissé Dávila, Ángel Ortega, Yosselin Gómez, Nereida Valero-Cedeño, Heliana Parra, Alexander Manzano, Teresa Véliz Castro, María Albornoz, Gabriel Cano, Joselyn Rojas-Quintero, Maricarmen Chacín, Valmore Bermúdez. Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. International Journal of Molecular Sciences 2021; 22(9): 4807 doi: 10.3390/ijms22094807
|
| 56 |
Ioannis Ilias, Costas Thomopoulos. Non-alcoholic fatty liver disease, diabetes medications and blood pressure. World Journal of Diabetes 2021; 12(10): 1809-1811 doi: 10.4239/wjd.v12.i10.1809
|
| 57 |
Igor V. Maev, Alexey A. Samsonov, Leonid B. Lazebnik, Elena V. Golovanova, Chavdar S. Pavlov, Elena I. Vovk, Vlad Ratziu, Kirill M. Starostin. A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease. Advances in Therapy 2020; 37(11): 4627 doi: 10.1007/s12325-020-01493-w
|
| 58 |
Tengrui Cao, Qian Zhu, Chao Tong, Aheyeerke Halengbieke, Xuetong Ni, Jianmin Tang, Yumei Han, Qiang Li, Xinghua Yang. Establishment of a machine learning predictive model for non-alcoholic fatty liver disease: A longitudinal cohort study. Nutrition, Metabolism and Cardiovascular Diseases 2024; doi: 10.1016/j.numecd.2024.02.004
|
| 59 |
Katarzyna Kozłowska-Petriczko, Ewa Wunsch, Jan Petriczko, Wing-Kin Syn, Piotr Milkiewicz. Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference. Journal of Clinical Medicine 2021; 10(7): 1507 doi: 10.3390/jcm10071507
|
| 60 |
Nima Motamed, Mahmoodreza Khoonsari, Mahshid Panahi, Nader Rezaie, Mansooreh Maadi, Fahimeh Safarnezhad Tameshkel, Hossein Keyvani, Mohammad Hadi Karbalaie Niya, Hossein Ajdarkosh, Seyyed Mohammad Miri, Farhad Zamani. The Incidence and Risk Factors of Non-Alcoholic Fatty Liver Disease: A Cohort Study from Iran. Hepatitis Monthly 2020; 20(2) doi: 10.5812/hepatmon.98531
|
| 61 |
A Lum Han. Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease. Diabetology & Metabolic Syndrome 2022; 14(1) doi: 10.1186/s13098-022-00811-2
|
| 62 |
Zong Miao, Kristina M. Garske, David Z. Pan, Amogha Koka, Dorota Kaminska, Ville Männistö, Janet S. Sinsheimer, Jussi Pihlajamäki, Päivi Pajukanta. Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease. Human Genetics and Genomics Advances 2022; 3(1): 100056 doi: 10.1016/j.xhgg.2021.100056
|
| 63 |
Ofir Ben-Assuli, Arie Jacobi, Orit Goldman, Shani Shenhar-Tsarfaty, Ori Rogowski, David Zeltser, Itzhak Shapira, Shlomo Berliner, Shira Zelber-Sagi. Stratifying individuals into non-alcoholic fatty liver disease risk levels using time series machine learning models. Journal of Biomedical Informatics 2022; 126: 103986 doi: 10.1016/j.jbi.2022.103986
|
| 64 |
Maryam Taghdir, Akram Salehi, Karim Parastouei, Sepideh Abbaszadeh. Relationship between diet quality and nonalcoholic fatty liver disease predictor indices in Iranian patients with metabolic syndrome: A cross‐sectional study. Food Science & Nutrition 2023; 11(10): 6133 doi: 10.1002/fsn3.3549
|
| 65 |
Matthias K. Auer, Günter K. Stalla, Mareike R. Stieg. Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas. Pituitary 2016; 19(5): 461 doi: 10.1007/s11102-016-0726-1
|
| 66 |
Nima Motamed, Amir Hossein Faraji, Mahmood Reza Khonsari, Mansooreh Maadi, Fahimeh Safarnezhad Tameshkel, Hossein Keyvani, Hossein Ajdarkosh, Mohammad Hadi Karbalaie Niya, Nader Rezaie, Farhad Zamani. Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran. Clinical Nutrition 2020; 39(2): 468 doi: 10.1016/j.clnu.2019.02.024
|
| 67 |
Mohammad Ariya, Farbod Koohpayeh, Alireza Ghaemi, Saeed Osati, Sayed Hossain Davoodi, Jalaledin Mirzay Razzaz, Gholamali Javedan, Elham Ehrampoush, Reza Homayounfar, Gianfranco D. Alpini. Assessment of the association between body composition and risk of non-alcoholic fatty liver. PLOS ONE 2021; 16(4): e0249223 doi: 10.1371/journal.pone.0249223
|
| 68 |
Alireza Naderi, Mojtaba Farjam, Maryam Mojarrad Sani, Ashkan Abdollahi, Abdulhakim Alkamel, Omid Keshavarzian, Reza Tabrizi. The association between nonalcoholic fatty liver disease and corrected QT interval prolongation among generally healthy Iranian population: Fasa Cohort Study (FACS). Clinical Cardiology 2023; 46(6): 615 doi: 10.1002/clc.24015
|
| 69 |
Nima Motamed, Mehdi Nikkhah, Mohammad Hadi Karbalaie Niya, Mahmoodreza khoonsari, Dhayaneethie Perumal, G. Hossein Ashrafi, Amir Hossein Faraji, Mansooreh Maadi, Hossein Ajdarkosh, Fahimeh Safarnezhad Tameshkel, Maziar Moradi-Lakeh, Seyyed Mohammad Miri, Shahram Arsang-Jang, Farhad Zamani. The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study. Clinics and Research in Hepatology and Gastroenterology 2021; 45(6): 101567 doi: 10.1016/j.clinre.2020.10.011
|
| 70 |
A Lum Han. Association between metabolic associated fatty liver disease and osteoarthritis using data from the Korean national health and nutrition examination survey (KNHANES). Inflammopharmacology 2021; 29(4): 1111 doi: 10.1007/s10787-021-00842-7
|
| 71 |
Amna Subhan Butt, Jalpa Devi. Polycystic Ovary Syndrome. 2024; : 92 doi: 10.1016/B978-0-323-87932-3.00021-9
|
| 72 |
M.ª Teófila Vicente Herrero, M.ª Victoria Ramírez-Iñiguez de la Torre, Ángel Arturo López González. Obesidad, hábitos de vida y valoración FLI en la población laboral española durante la pandemia. Revista Clínica de Medicina de Familia 2022; : 93 doi: 10.55783/150205
|